Juan Lu Selected Research

Epstein-Barr Virus Nuclear Antigens

1/2020	Mechanisms of Epstein-Barr virus nuclear antigen 1 favor Tregs accumulation in nasopharyngeal carcinoma.
2/2014	Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells.
8/2011	[Effect of Epstein-Barr virus nuclear antigen 1 on cell proliferation and cell cycle in nasopharyngeal carcinoma cells].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan Lu Research Topics

Disease

45	Neoplasms (Cancer) 03/2022 - 06/2004
22	Nasopharyngeal Carcinoma 03/2022 - 04/2009
13	Inflammation (Inflammations) 01/2022 - 09/2010
12	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2013
10	Infections 12/2019 - 06/2005
8	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 05/2003
7	Carcinogenesis 01/2022 - 03/2011
6	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2021 - 02/2007
4	Pneumonia (Pneumonitis) 01/2022 - 01/2017
4	Hypoxia (Hypoxemia) 01/2022 - 09/2006
4	Insulin Resistance 01/2021 - 01/2013
4	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020 - 01/2016
4	Hypersensitivity (Allergy) 01/2018 - 12/2017
3	Sepsis (Septicemia) 09/2022 - 01/2020
3	Stroke (Strokes) 01/2022 - 07/2007
3	Ischemic Stroke 01/2022 - 10/2016
3	Heart Failure 01/2022 - 11/2017
3	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2013
3	Parkinson Disease (Parkinson's Disease) 10/2020 - 01/2019
3	Wounds and Injuries (Trauma) 06/2018 - 04/2012
3	Craniocerebral Trauma (Head Injury) 05/2012 - 08/2008
3	Hypotension (Low Blood Pressure) 08/2008 - 09/2006
3	Colonic Neoplasms (Colon Cancer) 06/2004 - 09/2003
2	COVID-19 12/2021 - 03/2021
2	Acute Coronary Syndrome 11/2021 - 01/2021
2	Liver Failure 05/2021 - 08/2015
2	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2021
2	Obesity 01/2021 - 01/2013
2	Fibrosis (Cirrhosis) 01/2021 - 04/2019
2	Liver Diseases (Liver Disease) 01/2021 - 01/2016
2	Chronic Renal Insufficiency 01/2021 - 05/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 03/2015
2	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2020
2	Glioma (Gliomas) 07/2018 - 12/2009
2	Reperfusion Injury 10/2016 - 05/2010
2	Brain Ischemia (Cerebral Ischemia) 10/2016 - 05/2010
2	Prostatic Neoplasms (Prostate Cancer) 08/2016 - 04/2010
1	Endotoxemia 09/2022
1	Ischemia 01/2022

Drug/Important Bio-Agent (IBA)

15	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2011
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2010
11	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2003
8	Proteins (Proteins, Gene)FDA Link 03/2022 - 09/2005
8	Pharmaceutical PreparationsIBA 01/2022 - 12/2013
4	Long Noncoding RNAIBA 01/2022 - 01/2021
4	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 02/2007
3	LipopolysaccharidesIBA 09/2022 - 04/2011
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
3	Biological ProductsIBA 01/2022 - 02/2016
3	Messenger RNA (mRNA)IBA 01/2022 - 06/2009
3	C-Reactive ProteinIBA 01/2022 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2015
3	Epstein-Barr Virus Nuclear AntigensIBA 01/2020 - 08/2011
3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 12/2009
3	CytokinesIBA 08/2018 - 01/2016
3	Nicotine FDA Link 01/2018 - 12/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2012 - 08/2008
3	Hemoglobins (Hemoglobin)IBA 08/2008 - 09/2006
3	Decitabine FDA Link 02/2004 - 09/2003
3	MethyltransferasesIBA 02/2004 - 09/2003
2	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 09/2022 - 01/2020
2	Small Cytoplasmic RNAIBA 01/2022 - 01/2022
2	AlbuminsIBA 01/2022 - 01/2021
2	Interleukin-1 (Interleukin 1)IBA 01/2022 - 11/2017
2	Sincalide FDA Link 01/2022 - 02/2013
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 11/2017
2	5-Methylcytosine (5 Methylcytosine)IBA 01/2022 - 08/2016
2	Circular RNAIBA 01/2022 - 11/2021
2	AdiponectinIBA 01/2021 - 12/2020
2	baicalinIBA 01/2021 - 04/2011
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2021
2	LigandsIBA 01/2021 - 01/2017
2	Blood Proteins (Serum Proteins)IBA 01/2021 - 01/2019
2	Therapeutic UsesIBA 01/2021 - 12/2009
2	Oxygen (Dioxygen)IBA 01/2021 - 10/2019
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021 - 01/2017
2	Oxidopamine (6 Hydroxydopamine)IBA 10/2020 - 01/2019
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 01/2020
2	Opiate AlkaloidsIBA 01/2020 - 01/2020
2	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2020
2	Antihypertensive Agents (Antihypertensives)IBA 04/2018 - 05/2015
2	Cadherins (E-Cadherin)IBA 07/2017 - 12/2010
2	Interleukin-10 (Interleukin 10)IBA 01/2017 - 04/2011
2	PowdersIBA 07/2016 - 10/2010
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2016 - 04/2009
2	Endothelin-1 (Endothelin 1)IBA 06/2016 - 11/2014
2	hydroxide ionIBA 02/2013 - 04/2010
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2005 - 06/2005
2	Histones (Histone)IBA 06/2004 - 02/2004
2	Cyclin-Dependent Kinase Inhibitor p16IBA 02/2004 - 09/2003
1	Saline SolutionIBA 09/2022
1	N-methyladenosineIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022

Therapy/Procedure

18	Therapeutics 01/2022 - 12/2009
3	Immunotherapy 01/2022 - 02/2016
3	Drug Therapy (Chemotherapy) 01/2022 - 12/2009
2	Artificial Liver (Bioartificial Liver) 05/2021 - 01/2016
2	Lasers (Laser) 01/2021 - 01/2016
2	Moxibustion 08/2020 - 01/2019
2	Aftercare (After-Treatment) 01/2018 - 12/2013